Business Context and Reporting Period
This Form 6-K filing by EUDA Health Holdings Ltd covers the month of December 2025. The report details a material amendment to a warrant agreement previously entered into with an accredited investor.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a specific securities transaction.
Material Changes
On December 16, 2025, the Company amended a warrant agreement originally dated November 26, 2025, and issued on December 4, 2025. The key changes include:
- Exercise Price Reduction: The exercise price was lowered from $6.00 per share to $4.00 per share.
- Forced Exercise Threshold Reduction: The minimum closing price of the Company's ordinary shares on Nasdaq required to trigger a Forced Exercise was reduced from $7.50 to $6.00.
- Underlying Shares: The warrant remains exercisable into 2,000,000 newly-issued ordinary shares for an aggregate purchase price of $100,000.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operational outlook, or a discussion of general risks. The Company noted it will file a new prospectus supplement to reflect the amended warrant terms. The report includes a standard disclaimer that it does not constitute an offer to sell securities in jurisdictions where such an offer would be unlawful.
Investor Verification Checklist
- Verify the full text of the Warrant Amendment filed as Exhibit 1.1 for complete legal terms.
- Confirm the impact of the reduced exercise price ($4.00) on potential dilution of existing shareholders.
- Monitor the upcoming prospectus supplement to ensure all updated terms are accurately reflected in the Company's Registration Statement on Form F-3.
- Check the current Nasdaq closing price of EUDA Health Holdings Ltd to assess the proximity to the new Forced Exercise threshold of $6.00.